Chronic hepatitis B and IL28B rs12979860 polymorphism: preliminary study.

doi:10.1007/s11033-013-2730-0

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Chronic hepatitis B and IL28B rs12979860 polymorphism: preliminary study.

Molecular biology reports - 1 Nov 2013

Kandemir Özlem, Fidancı Senay Balcı, Demir Neslihan, Görür Ayşegül, Tamer Lülüfer

Abstract excerpt

The aim of this study is to evaluate the role of IL28B rs12979860 polymorphism on pegylated interferon (peg IFN) and oral antiviral treatment in chronic hepatitis B (CHB) patients and to investigate the relationship between the severities of illness with this polymorphism. 74 CHB patients who are received treatment, 61 asymptomatic carriers and 40 healthy controls were recruited in this study. Genomic DNA of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Time Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antiviral Agents

Share to Hepatitis B, Chronic

Share to Interferons

Share to Interleukins

Share to Severity of Illness Index

Share to Treatment Outcome

Share to Young Adult

Source

Open in PubMed

Identifiers

PMID: 24057245
DOI: 10.1007/s11033-013-2730-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chronic hepatitis B and IL28B rs12979860 polymorphism: preliminary study.PMID 24057245Read ↗

Association of rs12979860 and rs8099917 polymorphisms at IL28B gene with chronic hepatitis B and C, and non-viral liver disease patients IL28B rs8099917 G risk factor for hepatitis B patientsSemantic proximity Read ↗

Role of IL28-B polymorphisms in the treatment of chronic hepatitis B HBeAg-negative patients with peginterferon.Semantic proximity Read ↗

IL28B rs12979860 gene polymorphism in Egyptian patients with chronic liver disease infected with HCV.Semantic proximity Read ↗

Distribution of polymorphisms rs12979860, rs8099917 and rs12980275 IL28B in patients with chronic hepatitis C.Semantic proximity Read ↗

Impact of interleukin 28B rs12979860 C/T polymorphism on severity of disease and response to treatment in hepatitis delta.Semantic proximity Read ↗

Impact of IL28B genetic variation on HCV-induced liver fibrosis, inflammation, and steatosis: a meta-analysis.Semantic proximity Read ↗

Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patients.Semantic proximity Read ↗

SNP rs8099917 in gene IL28B might be associated with risk of chronic infection by HCV but not with response to treatment.Semantic proximity Read ↗

Distribution of IL28B Genotypes in Iranian Patients with Chronic Hepatitis C and Healthy IndividualsSemantic proximity Read ↗

Test of IL28B polymorphisms in chronic hepatitis C patients treated with PegIFN and ribavirin depends on HCV genotypes: results from a meta-analysis.Semantic proximity Read ↗

Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection.Semantic proximity Read ↗

Interleukin 28B.rs12979860 genotype does not affect hepatitis C viral load in Egyptians with genotype 4 chronic infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.